Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
N/A
1,100 Added 5.67%
20,500 $0
Q4 2022

Feb 14, 2023

BUY
$0.0 - $9.95 $0 - $6,964
700 Added 3.74%
19,400 $0
Q3 2022

Nov 15, 2022

BUY
$8.57 - $11.57 $5,142 - $6,942
600 Added 3.31%
18,700 $166,000
Q1 2022

May 13, 2022

BUY
$10.07 - $11.93 $1,007 - $1,193
100 Added 0.56%
18,100 $210,000
Q4 2021

Feb 14, 2022

SELL
$7.95 - $11.24 $10,335 - $14,612
-1,300 Reduced 6.74%
18,000 $200,000
Q3 2021

Nov 10, 2021

SELL
$9.22 - $12.44 $8,298 - $11,196
-900 Reduced 4.46%
19,300 $178,000
Q2 2021

Jul 30, 2021

SELL
$9.91 - $12.78 $36,667 - $47,286
-3,700 Reduced 15.48%
20,200 $227,000
Q1 2021

May 06, 2021

SELL
$10.44 - $12.22 $82,476 - $96,538
-7,900 Reduced 24.84%
23,900 $253,000
Q4 2020

Feb 08, 2021

SELL
$9.3 - $11.77 $99,519 - $125,950
-10,701 Reduced 25.18%
31,800 $345,000
Q3 2020

Nov 12, 2020

SELL
$7.59 - $10.8 $6,519 - $9,277
-859 Reduced 1.98%
42,501 $413,000
Q2 2020

Aug 13, 2020

BUY
$7.96 - $11.54 $111,917 - $162,252
14,060 Added 47.99%
43,360 $345,000
Q1 2020

May 14, 2020

BUY
$7.69 - $11.68 $19,225 - $29,200
2,500 Added 9.33%
29,300 $255,000
Q3 2019

Nov 14, 2019

BUY
$9.66 - $12.36 $27,048 - $34,608
2,800 Added 11.67%
26,800 $291,000
Q2 2019

Aug 14, 2019

BUY
$9.32 - $12.98 $35,555 - $49,518
3,815 Added 18.9%
24,000 $225,000
Q1 2019

May 14, 2019

BUY
$10.35 - $13.06 $25,719 - $32,454
2,485 Added 14.04%
20,185 $248,000
Q4 2018

Feb 13, 2019

BUY
$11.64 - $15.41 $10,476 - $13,869
900 Added 5.36%
17,700 $210,000
Q2 2018

Aug 13, 2018

SELL
$13.05 - $15.45 $6,525 - $7,725
-500 Reduced 2.89%
16,800 $250,000
Q1 2018

May 14, 2018

BUY
$12.0 - $14.45 $19,200 - $23,120
1,600 Added 10.19%
17,300 $226,000
Q4 2017

Feb 13, 2018

SELL
$11.65 - $13.35 $5,825 - $6,675
-500 Reduced 3.09%
15,700 $198,000
Q3 2017

Nov 13, 2017

BUY
$11.95 - $13.35 $193,590 - $216,270
16,200
16,200 $210,000

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.